摘要
目的:分析我院麻醉性镇痛药的应用情况,为临床合理使用麻醉药品提供依据.方法:统计我院1999～2004年门诊及住院患者人次和6种麻醉性镇痛药品的年用量并计算其年增减比率.结果:与1999年比,此后5年口服吗啡年用量分别增长26.99%、262.66%、619.00%、1 311.00%、1 632.12%;与2000年比,此后4年芬太尼贴剂年用量分别增长63.91%、385.65%、454.35%、622.17%;两药增幅均大于门诊及住院人次的增幅;1999年以后注射哌替啶年用量均在减少,分别减少了6.50%、5.54%、12.35%、9.43%、12.51%.结论:吗啡口服剂和芬太尼贴剂已经成为我院临床医师缓解肿瘤疼痛的首选;哌替啶已不再作为癌痛治疗的选择.
OBJECTIVE：To analyze the use of narcotic analgesics, in order to provide an evidence for rational use of narcotic analgesics in the clinic. METHODS ： Men - times of outpatients and inpatients and annual consumption of 6 narcotic analgesics during the period 1999 - 2004 were investigated and analyzed, annual rate of increase and decrease was also calculated. RESULTS： Compared with that of 1999, consumption of morphine for oral use annually increased by 26.99%, 262.66%, 619.00%, 1 311.00% and 1 632.12% in later 5 years; Compared with that of 2000, fentanyl transdermal system consumption annually increased by 63.91 %, 385.65 %, 454.35 % and 622.17 % in later 4 years. Amplification of these 2 drugs was higher than that of men - times of outpatients and inpatients. Pethidine ＇ s annual consumption decreased by 6.50%, 5.54%, 12.35%, 9.43% and 12.51% after 1999. CONCLUSION： Morphine for oral use and fentanyl transdermal system have become the first - choice drugs for relieving cancer pain in our hospital. Pethidine is no longer used as a choice for cancer pain.
出处
《中国医院用药评价与分析》
2005年第6期364-365,共2页
Evaluation and Analysis of Drug-use in Hospitals of China
